• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Roche Holding AG

Roche Holding AG

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Global Influenza Market Worth USD 10.2 Billion by 2022 - Analysis, Technologies & Forecasts Report 2016-2022 - Key Vendors: Abbott Labs, CSL, Roche Holding - Research and Markets

    Global Influenza Market Worth USD 10.2 Billion by 2022 - Analysis, Technologies & Forecasts Report 2016-2022 - Key Vendors: Abbott Labs, CSL, Roche Holding - Research and Markets

  2. EUROPE MARKETS: European Stocks Slump As Yellen's Rate Hike Message Sinks In

    EUROPE MARKETS: European Stocks Slump As Yellen's Rate Hike Message Sinks In

  3. UPDATE: European stocks slump as Yellen's rate hike message sinks in

    UPDATE: European stocks slump as Yellen's rate hike message sinks in

  4. EUROPE MARKETS: European Stocks Book A Loss As Rate-hike Signals Intensify

    EUROPE MARKETS: European Stocks Book A Loss As Rate-hike Signals Intensify

  5. UPDATE: European stocks book a loss as rate-hike signals intensify

    UPDATE: European stocks book a loss as rate-hike signals intensify

  6. Business Watch -- WSJ

    Business Watch -- WSJ

  7. EUROPE MARKETS: European Stocks Slump As Yellen's Rate Hike Message Sinks In

    EUROPE MARKETS: European Stocks Slump As Yellen's Rate Hike Message Sinks In

  8. European stocks slump as Yellen's rate hike message sinks in

    European stocks slump as Yellen's rate hike message sinks in

  9. FDA grants Roche Zika test emergency authorization

    FDA grants Roche Zika test emergency authorization

  10. Roche Receives US FDA Emergency Use Authorization for Zika Test -- Update

    Roche Receives US FDA Emergency Use Authorization for Zika Test -- Update

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.